Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
about
Laboratory animals as surrogate models of human obesity.Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot studyMechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery.All bariatric surgeries are not created equal: insights from mechanistic comparisons.Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.
P2860
Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
@en
Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
@nl
type
label
Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
@en
Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
@nl
prefLabel
Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
@en
Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
@nl
P1476
Liraglutide: a review of the first once-daily GLP-1 receptor agonist
@en
P2093
Bruce Bode
P304
P433
P577
2011-03-01T00:00:00Z